MAZE — Maze Therapeutics Inc. price, chart and key statistics

Price data

Price

$32.45

YTD price return

-21.68%

YTD total return

-21.68%

Next earnings

Nov 5, 2026

Market cap

1.8B2025-03 482.2M2026-10 1.8B+273.8% over the window

Enterprise value

1.5B

Shares outstanding

55.5M2024-12 2.4M2026-06 55.5M+2170.2% over the window

52W low

$21.95

52W high

$53.65

From 52W high

-39.52%

From 52W low

+47.84%

52W range

33%

Volume

Rel volume

1.68×

30D volume

933.9K

30D $ vol

25.1M

Fundamentals

EPS (ttm)

-$2.522024-12 $1.252026-06 -$2.52-301.5% over the window

FCF (ttm)

-106.8M2024-12 74.8M2026-06 -106.8M-242.8% over the window

FCF/share

-$1.922024-12 $30.572026-06 -$1.92-106.3% over the window

Book value/share

$8.162024-12 -$127.182026-06 $8.16-106.4% over the window

ROE

-29.48%2025-12 -36.9%2026-06 -29.5%-20.2% over the window

ROA

-25.13%2024-12 21.7%2026-06 -25.1%-215.7% over the window

Debt / equity

0.09×

Current ratio

18.312024-12 9.762026-06 18.31+87.7% over the window

Growth (CAGR, ttm) · 10Y

Shares

+26.70%2025-06-30 → 2026-06-3043.9M → 55.5M (+26.7% total)n/an/an/a

Per-share growth (CAGR, ttm) · 10Y

Book value/share

+36.43%2025-06-30 → 2026-06-30$5.98 → $8.16 (+36.4% total)n/an/an/a

Price

+9.08%2025-10-20 → 2026-10-20$29.75 → $32.45 (+9.1% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.n/an/an/a

Total return

+9.08%2025-10-20 → 2026-10-20$29.75 → $32.45 (+9.1% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.n/an/an/a

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)Price ÷ TTM diluted EPS. Net income carries everything below the operating line, including one-off gains. Negative when the trailing year lost money.

-12.9×2025-03 9.232026-10 -13.49-246.2% over the window

Fwd P/E

-10.1×

P/B (mrq)Market cap ÷ stockholders' equity at the most recent quarter end.

4.0×2025-03 1.652026-10 3.98+140.9% over the window

FCF yield (ttm)TTM free cash flow ÷ market cap — the inverse of P/FCF.

-5.93%2024-12 15.5%2026-06 -6.4%-141.5% over the window

Buyback yield (realized, 1y)1 − shares_at(2026-06-30) ÷ shares_at(2025-06-30) = 1 − 55.5M ÷ 43.9M. Point-in-time share counts from the company's own SEC filings (the same count at both ends), published only when the cash flow statement shows repurchases inside that window. A falling price can't inflate it; negative means net dilution.

-26.70%

Shareholder yield (realized, 1y)Buyback leg + dividend leg: shares retired over the year (-26.70%) + dividends paid over that year ($0) ÷ market_cap_at(2025-06-30) ($538.1M). Both legs are measured against the start of the window, so a payout can't shrink its own denominator.

-26.70%

Buyback yield (cash, ttm)Buybacks net of issuance over the trailing twelve months ($0) ÷ today's market cap ($1.8B). Dollars SPENT over what the company is worth NOW — a stock that fell after buying reads high.

0.00%2024-12 0.0%2026-06 0.0%

Shareholder yield (cash, ttm)(TTM buybacks net of issuance $0 + TTM dividends $0) ÷ today's market cap ($1.8B). Same caveat as the cash buyback yield.

0.00%2024-12 0.0%2026-06 0.0%